EMJ Podcast: Insights For Healthcare Professionals

Are we entering a new era in the fight against antimicrobial resistance (AMR)? Listen to our latest podcast series to hear how sustainable access to effective antibiotics and diagnostic development may impact the battle against AMR.

8. This week, Jonathan is joined by Silvia Munoz-Price, Infectious Diseases Physician; Hospital Epidemiologist; and former Chief Quality & Safety Officer, Virginia Commonwealth University Health, USA. The pair discuss lessons from the COVID-19 pandemic, vaccine hesitancy, and health equity.

Use the following timestamps to navigate this episode:

(00:09)-Introduction (02:46)-Hospital Consolidations (08:20)-Reducing safety events (10:12)-Spotting trends in quality metrics (15:10)-Vaccine hesitancy (19:44)-Preparedness ahead of COVID-19 (23:36)-How can we encourage vaccination (24:41)-The American healthcare system (31:00)-Removing politics from medicine (40:27)-Zoonoses and changing migration patterns (43:59)-Encouraging a career in epidemiology (45:07)-Silvia's three wishes

This week, Jonathan Sackier is joined by Sarah Blagden, a pioneer of experimental oncology research, and CEO of RNA Guardian Ltd, a biotechnology company dedicated to identifying early cancer biomarkers.

Timestamps:

(00:00)-Introduction

(01:30)-Recent reads and tweets

(04:57)-Tweets and cancer acceptance

(07:36)-Sarah's journey into oncology

(09:33)-Exploring new drugs and trials

(11:48)-Global experiences and improving the clinical trial environment

(14:28)-Genetics, research, and oncology

(17:27)-Dysregulation of mRNA translation cancer

(18:36)-The future of prevention

(22:33)-Use of metformin

(26:36)-Join us for more next time!

This week, Jonathan Sackier is joined by Carlos Caldas, a world-leading expert in breast cancer research and clinician scientist at the University of Cambridge. Together, they explore how genomic-based classifications of breast cancer are transforming treatment strategies and improving patient outcomes. 

Timestamps:  (00:00) – Introduction 

(02:00) – Carlos's favourite cuisine  

(03:32) – Carlos's journey into oncology  

(08:30) – The redefinition of breast cancer  

(14:30) – How this taxonomy influences clinical care  

(20:15) - Patient-derived xenografts for breast cancer  

(28:00) - Circulating plasma cell-free tumour DNA as a marker of tumour burden  

(33:00) – Patient derived tumour cells for drug screening  

(35:00) – Vitamin B5 and environmental factors in oncology  

(38:44) – Current developments in breast cancer aetiology, diagnosis or treatment  

(44:00) – The three wishes for the future of healthcare  

(45:00) – Outro  

This week Jonathan is joined by Isabelle Amigues, CEO and Founder of UnabridgedMD, Denver, Colorado, USA. Together, they discuss the first part of her career as an academic clinician followed by how her diagnosis of Stage IV breast cancer shaped her approach to use the best in data-driven Western medicine combined with traditional Eastern healing.

Timestamps:  

(00:00) - Introduction

(02:02) - Isabelle's unique hobby: rock climbing

(03:33) - Isabelle's journey into rheumatology

(05:58) - Being diagnosed with Stage IV breast cancer

(14:17) - The mind-body connection

(20:25) - "Hope driven by science"

(24:25) - The benefits of holistic approaches

(32:29) - Psychological distress in healthcare professionals

(37:10) - Synovial fluid and biomarker proteins

(39:48) - Isabelle's three wishes for healthcare

(42:37) - Outro

In this episode of Hema Now, Dr. Jonathan Sackier welcomes Professor Antonio Almeida, a leader in hematology and the 2024 President of the EHA. They delve into the highlights from this year's EHA Congress, discuss the founding of the Católica Medical School, and explore the transformative role of AI in healthcare.  

Timestamps: 

(00:00) -Introduction 

(01:40) -Reflection on the EHA 2024 Congress 

(06:10) -Approaches for future congresses 

(10:30) -Proudest accomplishments and EHA education initiatives  

(17:00) -Reflections on the treatment landscape of blood-related conditions  

(26:00) -Importance of registries in uncovering more about these diseases 

(30:10) -Potential of AI in hematology 

(32:50) -Role of public policy in shaping the future of hematology 

(37:00) -What drove Antonio to found a medical school 

(40:00) -Antonio's three wishes 

This week, Jonathan Sackier is joined by Prof. Carlos Caldas, a world-leading expert in breast cancer research and clinician scientist at the University of Cambridge. Together, they explore how genomic-based classifications of breast cancer are transforming treatment strategies and improving patient outcomes. 

Timestamps:

(00:00) – Introduction 

(02:00) – Carlos's favourite cuisine  

(03:32) – Carlos's journey into oncology  

(08:30) – The redefinition of breast cancer  

(14:30) – How this taxonomy influences clinical care  

(20:15) - Patient-derived xenografts for breast cancer  

(28:00) - Circulating plasma cell-free tumour DNA as a marker of tumour burden  

(33:00) – Patient derived tumour cells for drug screening  

(35:00) – Vitamin B5 and environmental factors in oncology  

(38:44) – Current developments in breast cancer aetiology, diagnosis or treatment  

(44:00) – The three wishes for the future of healthcare  

(45:00) – Outro

This week, Jonathan Sackier is joined by Prof. Carlos Caldas, a world-leading expert in breast cancer research and clinician scientist at the University of Cambridge. Together, they explore how genomic-based classifications of breast cancer are transforming treatment strategies and improving patient outcomes. 

Timestamps:

(00:00) – Introduction 

(02:00) – Carlos’s favourite cuisine  

(03:32) – Carlos’s journey into oncology  

(08:30) – The redefinition of breast cancer  

(14:30) – How this taxonomy influences clinical care  

(20:15) - Patient-derived xenografts for breast cancer  

(28:00) - Circulating plasma cell-free tumour DNA as a marker of tumour burden  

(33:00) – Patient derived tumour cells for drug screening  

(35:00) – Vitamin B5 and environmental factors in oncology  

(38:44) – Current developments in breast cancer aetiology, diagnosis or treatment   

(44:00) – The three wishes for the future of healthcare  

(45:00) – Outro

In this episode, Jonathan is joined by John H. Stone, Professor of Medicine at Harvard Medical School and The Edward A. Fox Chair in Medicine at Massachusetts General Hospital.  Stone discusses his groundbreaking work in systemic vasculitis, including granulomatosis with polyangiitis and ANCA-associated vasculitis. He also shares insights into the emerging field of IgG4-related disease and the exciting possibility of the first approved therapy for this condition. Alongside, he delves into his efforts to minimise glucocorticoid toxicity and his work through the IgG4ward! Foundation.

Timestamps:

(00:30) – Introduction

(04:00) – Stone's journey into rheumatology

(07:28) – WEGET trial

(10:30) – Developments in IgG4-related disease and the path to therapy approval

(15:52) – Key advancements in the treatment of granulomatosis with polyangiitis

(18:04) – Glucocorticoid toxicity and the Glucocorticoid Toxicity Index (GTI)

(20:34) – The IgG4ward! Foundation

(23:48) – Two Pearls and a Myth

(26:45) – Stone's three wishes for rheumatology

In this exclusive podcast, experts in the field, Andrew Foy, Penn State Health Milton S. Hershey Medical Center, and Ed Filippone, Sidney Kimmel Medical College of Thomas Jefferson University, both in Pennsylvania, USA, explore the burden of hypertension on patients and give insights into how to best care for these patients. 

Topics covered include:

• patient difficulties when managing hypertension;
• blood pressure measurement and monitoring, and how to best support patients through this;
• hypertension medications and treatment resistance; and
• navigating conflicting advice and guidelines.